Thus, mutated (m) KRAS represents a cancer driver oncoprotein, and KRAS codon 12 mutations are frequently found in pancreatic ductal adenocarcinomas (PDACs), colorectal adenocarcinomas (CRCs), and non-small-cell lung cancers (NSCLCs) [14–16]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.